Ondansetron Tablet, Orally Disintegrating
Product Images NDC 68001-247

9 FDA label images from Bluepoint Laboratories · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 68001-247). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure-base (Structure Base)

Structure-base (Structure Base)
Chemical structure diagram of Ondansetron showing its molecular framework with ring systems and functional groups including a ketone, methyl groups, and nitrogen-containing heterocycles.*
FDA Label Image

Ondasetron Orally Disintegrating Tablets Usp 4mg (Ondansetron Od Tablets Usp 4mg 30 Tablets Labels Rev 12 21)

Ondasetron Orally Disintegrating Tablets Usp 4mg (Ondansetron Od Tablets Usp 4mg 30 Tablets Labels Rev 12 21)
Ondansetron Orally Disintegrating Tablets, USP 4 mg, tablet form in a 30-tablet package. The label shows BluePoint Laboratories as the manufacturer and labeler, includes dosage information, storage instructions, and a barcode. It specifies the tablets contain 4 mg ondansetron and mentions phenylalanine as an ingredient.*
FDA Label Image

Ondansetron Od Tabs Usp 4mg Label Rev 01-26 (Ondansetron Od Tabs Usp 4mg Label Rev 01 26)

Ondansetron Od Tabs Usp 4mg Label Rev 01-26 (Ondansetron Od Tabs Usp 4mg Label Rev 01 26)
Ondansetron Orally Disintegrating Tablets, USP 4 mg, in a carton label by BluePoint Laboratories. The label indicates 30 tablets, manufactured by Glenmark Pharmaceuticals Limited, India, and includes storage and handling instructions, a barcode, and a contact phone number for questions. The label displays the NDC 68001-246-04 and marks the product as Rx only.*
FDA Label Image

Ondasetron Orally Disintegrating Tablets (Ondansetron Od Tablets Usp 8mg 30 Tablets Labels Rev 12 21)

Ondasetron Orally Disintegrating Tablets (Ondansetron Od Tablets Usp 8mg 30 Tablets Labels Rev 12 21)
Ondansetron Orally Disintegrating Tablets, USP 8 mg, oral disintegrating tablets in a 30-tablet package. The label includes dosage details, storage instructions, manufacturer BluePoint Laboratories, and NDC 68001-247-04. The label also cautions about phenylalanine content for phenylketonurics and includes barcode and lot information.*
FDA Label Image

Ondansetron Od Tabs Usp 8mg Label Rev 01-26 (Ondansetron Od Tabs Usp 8mg Label Rev 01 26)

Ondansetron Od Tabs Usp 8mg Label Rev 01-26 (Ondansetron Od Tabs Usp 8mg Label Rev 01 26)
Ondansetron Orally Disintegrating Tablets USP, 8 mg strength, in a package of 30 tablets. Manufactured by Glenmark Pharmaceuticals Limited and BluePoint Laboratories, this oral tablet is labeled for prescription use only. The label includes storage instructions, usual dosage advice, and a barcode with NDC 68001-247-04.*
FDA Label Image

Ondansetron Orally Disintegrating Tablets (Ondansetron Od Tablets Usp 8mg Carton Rev 11 21)

Ondansetron Orally Disintegrating Tablets (Ondansetron Od Tablets Usp 8mg Carton Rev 11 21)
Ondansetron Orally Disintegrating Tablets USP 8 mg packaging label from BluePoint Laboratories. The label indicates 30 tablets (3 blister cards of 10 tablets each) with storage instructions and a warning about phenylalanine. It includes usage illustrations and barcode labels on a white background with blue and magenta accents.*
FDA Label Image

Ondansetron Od Tabs Usp 8mg Carton Rev 04-26 (Ondansetron Od Tabs Usp 8mg Carton Rev 04 26)

Ondansetron Od Tabs Usp 8mg Carton Rev 04-26 (Ondansetron Od Tabs Usp 8mg Carton Rev 04 26)
Ondansetron Orally Disintegrating Tablets, USP 8 mg packaging label by BluePoint Laboratories. The carton shows 30 tablets (3 cards each with 10 unit-of-use blisters). The label includes storage instructions, phenylalanine warning, and usage instructions illustrated on blister peel panels. The product is Rx only with NDC 68001-247-17.*
FDA Label Image

Ondansetron Orally Disintegrating Tablets (Ondansetron Od Tablets Usp 4mg Carton Rev 11 21)

Ondansetron Orally Disintegrating Tablets (Ondansetron Od Tablets Usp 4mg Carton Rev 11 21)
Ondansetron Orally Disintegrating Tablets USP 4 mg packaging label from BluePoint Laboratories features product name, strength, dosage form, storage instructions, phenylketonurics warning, and quantity of 30 tablets (3 blister cards of 10 each). The label includes manufacturer and barcode information, along with illustrated patient instructions for use showing step-by-step tablet administration.*
FDA Label Image

Ondansetron Od Tabs Usp 4mg Carton Rev 04-26 (Ondansetron Od Tabs Usp 4mg Carton Rev 04 26)

Ondansetron Od Tabs Usp 4mg Carton Rev 04-26 (Ondansetron Od Tabs Usp 4mg Carton Rev 04 26)
Packaging label for Ondansetron Orally Disintegrating Tablets, USP 4 mg, by BluePoint Laboratories. The label includes product name, strength, dosage form, NDC 68001-246-17, and storage instructions. It indicates 30 tablets per package, divided into 3 cards each containing 10 unit-of-use blisters. Instructions for tablet removal from blister pack using dry hands are shown. Manufacturer details and phenylalanine warning are also present.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.